1Hokanson JE, Austin MA. Plasma Triglyceridelevel is a risk factor for cardiovaseular disease independent of high-density lipoprotein cholesterol level : a meta-analysis of population-based prospective studies [J]. Cardiovasc Risk, 1996,3:213.
2Chappell DA, Medh JD. Receptor-mediated mechanisms of lipoprotein remnant catabolism[J]. Rrog Lipid ties, 1998,37 (6):393.
3Moulin P. Cholesteryl ester transfer protein : an enigmatic protein [ J ]. Honn Res, 1996,45 (3 - 5) :238.
4Schonfeld G. Inherited disorders of lipid transport [ J ]. Endocrinol Metab Clin North Am, 1990, 19: 229.
5Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protei[J]. Annu Rev Genomics hum Genet, 2000, 1:507.
6Nordestgard B G, Wootton R, Lewis B, et al. Selective retention of VLDL, IDL and LDL in the arterial intima of geneticlly byperlipidemic rabbits in vivo: molecular size as a determinant of fractional loss from the intima-inner media[J]. Arterioscler Thrmb Vasc Biol, 1995,15(4):534.
7Doi H, Kugiyama K, Ohgushi M, et al. Remnants of chylomicron and very low density lipoprotein impair endothelium-depedent vasore-laxation[J]. Atherosclerosis, 1998,137 : 341.
8John C Rutledge, Mabte M Woo, Allen A Rezai, et al. Lipoprotein lipase increases lipoprotein binding to the artery, wall and increases endothelial layer pemeability by formation of lipolysis products [ J ]. Circulation Research, 1997,80:819.
9Doi H, Kugiyama K, Oka H, et al. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism[ J ]. Circulation, 2000, 102 : 670.
10Saniabadi AR, Umenura K, Shimoyama M, et al. Aggregation of human blood platelets by remnant- like lipoprotein particles of plasma chylomicrons and very low density pipoproteins[ J]. Thromb Heamost, 1997,77: 996.
5Twickler T B,Dallinga-Thie G M,Cohn J S,et al.Elevated remnant-like particle cholesterol concentration; a characteristic feature of the atherogenic lipoprotein phenotype[J].Circulation,2004,109(16):1918-1925.
6Ohara N,Takeichi S,Nait o Y,et al.Remnant-like particles from subjects who died of coronary artery disease suppress NO synthase activity and attenuate endothelium-dependent vasorelaxation[J].Clin Chem Acta,2003,338(1-2):151 -156.
7Kawakami A,Tanaka A,Nakajma K,et al.Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions[J].Circ Res,2002,91(3):263-271.
8Doi H,Kugiyama K,Oka H,et al.Remnant lipoprotein induce proatherothrom bogenic molecules in endothelial cells through a redox sensitive mechanism[J].Circulation,2000,102(6):670-676.
9Yamazaki M,Uchiyama S,Xiong Y,et al.Effect of remnant-like particle on shear-induced platelet activation and its inhibition by antiplatelet agents[J].Thromb Res,2005,115 (3):211-218.
